Sharon Mates - Mar 9, 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Chairman, President & CEO, Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Mar 9, 2022
Transactions value $
$110,547
Form type
4
Date filed
3/10/2022, 03:13 PM
Previous filing
Feb 25, 2022
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise $111K +38.9K +3.56% $2.84* 1.13M Mar 9, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Options Exercise $0 -38.9K -100% $0.00* 0 Mar 9, 2022 Common Stock 38.9K $2.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.